Treace Medical Concepts, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -22.1% | -16.8% | -14.6% |
| FY2022 | -70.7% | -37.8% | -26.9% |
| FY2023 | -35.9% | -25.9% | -19.7% |
| FY2024 | -49.4% | -33.5% | -25.7% |
| FY2025 | -67.6% | -41.3% | -31.0% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -22.1% | -16.8% | -14.6% |
| FY2022 | -70.7% | -37.8% | -26.9% |
| FY2023 | -35.9% | -25.9% | -19.7% |
| FY2024 | -49.4% | -33.5% | -25.7% |
| FY2025 | -67.6% | -41.3% | -31.0% |